{"id":"https://genegraph.clinicalgenome.org/r/27e6f46e-2a60-45b4-8aee-76940ec7b4d1v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between *COX20* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of February 17, 2022. *COX20* encodes a Cytochrome *c* oxidase (complex IV) assembly factor. \n\n*COX20* was first reported in relation to autosomal recessive mitochondrial disease in 2013 (PMID: 23125284). While various names have been given to the constellation of features seen in those with *COX20*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *COX20 *phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included seven unique variants, including one nonsense (occurring in the last exon, 4/4), two intronic, and four missense variants, in 16 probands across seven publications from 2013-2021 (PMIDs: 23125284, 30656193, 32606554, 24202787, 31079202, 32999401, 33751098). Of note, the p.Arg14Lys and p.Thr52Pro variants appear to be founder variants, in the Eastern Chinese and Turkish populations, respectively, while the c.157+3G>C and p.Trp74Cys variants appear to be recurrent. *COX20* pathogenic variants were first reported in a child with ataxia, hypotonia, developmental delay, and short stature in the setting of complex IV deficiency in muscle and skin.  Subsequent publications have shown expansion of the phenotypic spectrum that ranges from childhood to adolescent onset sensory neuropathy, dystonia, and sensory ataxia, as well as muscle weakness, intellectual disability, and cerebellar atrophy. Loss-of-function is implicated as the mechanism of disease. This gene-disease association is also supported by known biochemical function, functional alteration in patient cells, functional alteration in non-patient cells, rescue in patient cells, and model systems (PMIDs: 22095077, 24403053, 23125284). \n\nIn summary, there is definitive evidence to support this gene-disease relationship, including that more than three years have elapsed since the first proposal of the association. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on February 17, 2022 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/27e6f46e-2a60-45b4-8aee-76940ec7b4d1","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2391b81d-cfd2-4862-b71b-0418794539c3","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2391b81d-cfd2-4862-b71b-0418794539c3_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2022-02-17T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/2391b81d-cfd2-4862-b71b-0418794539c3_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2022-07-01T20:57:26.725Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2391b81d-cfd2-4862-b71b-0418794539c3_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/559675ac-4ddf-424a-bab2-4b96b4cc6474_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef18bdd5-a8ad-463b-929b-763919297b53","type":"EvidenceLine","dc:description":"0.1 (default) + (0.4 Western blot in constructed plasmid expressing W74C showed 70% decreased in COX20 expression HEK293T cells) + 0.4 (fxnal studies in patient 5 cell line)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef18bdd5-a8ad-463b-929b-763919297b53_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 (default) + (0.4 Western blot in constructed plasmid expressing W74C showed 70% decreased in COX20 expression HEK293T cells)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ef18bdd5-a8ad-463b-929b-763919297b53_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/eb98a859-82d3-4d22-b863-624852bbf88d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198076.6(COX20):c.222G>T (p.Trp74Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1486170"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6c0859e8-4369-44c8-991d-941a325a58a7","type":"EvidenceLine","dc:description":"Founder variant default ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c0859e8-4369-44c8-991d-941a325a58a7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Founder variant score at 0.5","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6c0859e8-4369-44c8-991d-941a325a58a7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198076.6(COX20):c.41A>G (p.Lys14Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16603677"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/559675ac-4ddf-424a-bab2-4b96b4cc6474","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","rdfs:label":"Family 4 II-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":5,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},{"id":"https://genegraph.clinicalgenome.org/r/eb98a859-82d3-4d22-b863-624852bbf88d"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000763","obo:HP_0010871","obo:HP_0002460","obo:HP_0001761"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ef18bdd5-a8ad-463b-929b-763919297b53_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/6c0859e8-4369-44c8-991d-941a325a58a7_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/907955f1-2cba-41ca-8e4d-5849518e3aa5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/132b2b35-18ff-4cac-95d6-399119a3f0d6","type":"EvidenceLine","dc:description":"0.1 (default) + (0.4 Western blot in constructed plasmid expressing S33Lshowed 50% decreased in COX20 expression HEK293T cells) ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/132b2b35-18ff-4cac-95d6-399119a3f0d6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"rd","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/132b2b35-18ff-4cac-95d6-399119a3f0d6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/7f269d38-9824-413b-997b-6113f1121ab1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198076.6(COX20):c.98C>T (p.Ser33Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345676289"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/50a49ffc-26ce-4b17-b6b2-404796f6d20b","type":"EvidenceLine","dc:description":"Founder variant default ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50a49ffc-26ce-4b17-b6b2-404796f6d20b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Founder variant ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/50a49ffc-26ce-4b17-b6b2-404796f6d20b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/907955f1-2cba-41ca-8e4d-5849518e3aa5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","rdfs:label":"Family 6 II-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},{"id":"https://genegraph.clinicalgenome.org/r/7f269d38-9824-413b-997b-6113f1121ab1"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0010871","obo:HP_0000763"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/50a49ffc-26ce-4b17-b6b2-404796f6d20b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/132b2b35-18ff-4cac-95d6-399119a3f0d6_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/aae647c3-cfcf-4d65-9bfb-e39d2d9f0d90_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/960fe8e8-683e-4432-b7c9-e85e2e6f0056","type":"EvidenceLine","dc:description":"AF of p.W74C 0.000006579 , 1 allele in gnomADv3.1.2\nhttps://gnomad.broadinstitute.org/variant/1-244843041-G-T?dataset=gnomad_r3\n\n0.1 (default) + 0 (not de novo) + 0 (no fxnal evidence)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/960fe8e8-683e-4432-b7c9-e85e2e6f0056_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31079202","allele":{"id":"https://genegraph.clinicalgenome.org/r/eb98a859-82d3-4d22-b863-624852bbf88d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e9ffd2b5-addf-4256-b640-c6029c13d47d","type":"EvidenceLine","dc:description":"Founder variant default scoring\nPMID: 33751098","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9ffd2b5-addf-4256-b640-c6029c13d47d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"See Otero et al 2019","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/e9ffd2b5-addf-4256-b640-c6029c13d47d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31079202","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/aae647c3-cfcf-4d65-9bfb-e39d2d9f0d90","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31079202","rdfs:label":"II-3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":9,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/eb98a859-82d3-4d22-b863-624852bbf88d"},{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001263","obo:HP_0012534","obo:HP_0009830","obo:HP_0001260","obo:HP_0003198","obo:HP_0001249","obo:HP_0002359"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/960fe8e8-683e-4432-b7c9-e85e2e6f0056_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e9ffd2b5-addf-4256-b640-c6029c13d47d_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/2391b81d-cfd2-4862-b71b-0418794539c3_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b300781-f2ff-468c-95df-eed8ddeb4e54_proband_segregation","type":"FamilyCosegregation","dc:description":"Insufficient number of segregations (2 only)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656193","rdfs:label":"Subject 2 Family","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/5b300781-f2ff-468c-95df-eed8ddeb4e54","type":"Family","rdfs:label":"Subject 2 Family","member":{"id":"https://genegraph.clinicalgenome.org/r/fc021272-2e9c-483e-8a00-e0b7d241c5d3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656193","rdfs:label":"Subject 2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},{"id":"https://genegraph.clinicalgenome.org/r/8649f44d-0204-4207-bf33-aeee2bc89d70","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198076.6(COX20):c.157+3G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1486102"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000763","obo:HP_0002268","obo:HP_0000716","obo:HP_0001251","obo:HP_0001268","obo:HP_0000486","obo:HP_0001260"],"previousTesting":true,"previousTestingDescription":"Karyotype and Cytogenetic microarray, Freidreich Ataxia testing, ","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8930a49c-b3fa-490c-8066-0ccc4b834323_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656193","allele":{"id":"https://genegraph.clinicalgenome.org/r/8649f44d-0204-4207-bf33-aeee2bc89d70"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/be1cfd26-04bd-4ac1-8e1c-a8733cc579d1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656193","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/fc021272-2e9c-483e-8a00-e0b7d241c5d3"}},{"id":"https://genegraph.clinicalgenome.org/r/117f78a8-32d5-4a18-9e13-3ffa390bc483_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32999401","rdfs:label":"Family of 4 and 5","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/117f78a8-32d5-4a18-9e13-3ffa390bc483","type":"Family","rdfs:label":"Family of 4 and 5","member":{"id":"https://genegraph.clinicalgenome.org/r/38ff061b-16e2-4760-b0c9-877e84424b3f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32999401","rdfs:label":"Case 4","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/8649f44d-0204-4207-bf33-aeee2bc89d70"},{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001257","obo:HP_0000365","obo:HP_0002317","obo:HP_0002460","obo:HP_0000763"],"previousTesting":true,"previousTestingDescription":"negative results in brain and spine MRI, Charcot-Marie-Tooth and Friedreich ataxia-specific genetic-testing.","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e098ea2c-d1c2-41c3-8c3d-4ec887ca5085_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32999401","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/d04f07a8-f26d-4ea8-bf02-33d7e6d939c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32999401","allele":{"id":"https://genegraph.clinicalgenome.org/r/8649f44d-0204-4207-bf33-aeee2bc89d70"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000365","obo:HP_0000763","obo:HP_0001257","obo:HP_0002317","obo:HP_0002460"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/38ff061b-16e2-4760-b0c9-877e84424b3f"}},{"id":"https://genegraph.clinicalgenome.org/r/ef509777-3ad1-4eff-ac14-b047720f1555_proband_segregation","type":"FamilyCosegregation","dc:description":"Insufficient number of segregations","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24202787","rdfs:label":"Index Family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/ef509777-3ad1-4eff-ac14-b047720f1555","type":"Family","rdfs:label":"Index Family","member":{"id":"https://genegraph.clinicalgenome.org/r/1ff2a477-dc5e-4030-9768-5d8ca16a5f56","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24202787","rdfs:label":"Index Patient ","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/66391759-c953-4e7f-8ab7-8520d5cf9d76","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198076.6(COX20):c.154A>C (p.Thr52Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA144003"}},"detectionMethod":"Exome done followed up by sanger sequencing of COX20 after identification of variants","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001260","obo:HP_0001272","obo:HP_0001332","obo:HP_0001251","obo:HP_0000763"],"previousTesting":true,"secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7d5da76c-3592-4092-a97c-38af78af7add_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24202787","allele":{"id":"https://genegraph.clinicalgenome.org/r/66391759-c953-4e7f-8ab7-8520d5cf9d76"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001260","obo:HP_0001251","obo:HP_0001272","obo:HP_0000763"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1ff2a477-dc5e-4030-9768-5d8ca16a5f56"}},{"id":"https://genegraph.clinicalgenome.org/r/2dd7ef91-3d29-406d-bc35-5041e02f31f9_proband_segregation","type":"FamilyCosegregation","dc:description":"Insufficient number of segregations","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31079202","rdfs:label":"Xu et al 2019 Paper Family","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/2dd7ef91-3d29-406d-bc35-5041e02f31f9","type":"Family","rdfs:label":"Xu et al 2019 Paper Family","member":{"id":"https://genegraph.clinicalgenome.org/r/aae647c3-cfcf-4d65-9bfb-e39d2d9f0d90"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/aae647c3-cfcf-4d65-9bfb-e39d2d9f0d90"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/38ff061b-16e2-4760-b0c9-877e84424b3f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d04f07a8-f26d-4ea8-bf02-33d7e6d939c7","type":"EvidenceLine","dc:description":"NOT DESCRIBED AS FOUNDER YET","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d04f07a8-f26d-4ea8-bf02-33d7e6d939c7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"NOT DESCRIBED AS FOUNDER YET","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d04f07a8-f26d-4ea8-bf02-33d7e6d939c7_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e098ea2c-d1c2-41c3-8c3d-4ec887ca5085","type":"EvidenceLine","dc:description":"FOUNDER VARIANT","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e098ea2c-d1c2-41c3-8c3d-4ec887ca5085_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"FOUNDER VARIANT","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e098ea2c-d1c2-41c3-8c3d-4ec887ca5085_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/38ff061b-16e2-4760-b0c9-877e84424b3f"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/dc6b5a19-afd0-43d3-a54a-fff4e90cd5d1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72bed75d-4690-499c-9905-0595f728fd4e","type":"EvidenceLine","dc:description":"Founder variant in Turkish population see Doss et al 2014 (default score 0.5 per variant)","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72bed75d-4690-499c-9905-0595f728fd4e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Founder variant in Turkish population see Doss et al 2014 (default score 0.5 per variant)","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/72bed75d-4690-499c-9905-0595f728fd4e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32606554","allele":{"id":"https://genegraph.clinicalgenome.org/r/66391759-c953-4e7f-8ab7-8520d5cf9d76"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/dc6b5a19-afd0-43d3-a54a-fff4e90cd5d1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32606554","rdfs:label":"Ozcanyuz Case 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/66391759-c953-4e7f-8ab7-8520d5cf9d76"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/72bed75d-4690-499c-9905-0595f728fd4e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/671268c6-0c71-4af3-97b5-d851d9a555e6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/553017e7-9e66-4b94-8a9a-b7e987e43790","type":"EvidenceLine","dc:description":"Founder variant default scoring 0.5 per variant","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/553017e7-9e66-4b94-8a9a-b7e987e43790_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Founder variant","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/553017e7-9e66-4b94-8a9a-b7e987e43790_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/671268c6-0c71-4af3-97b5-d851d9a555e6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","rdfs:label":"Family 2 II-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000763","obo:HP_0001761","obo:HP_0010871"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/553017e7-9e66-4b94-8a9a-b7e987e43790_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/578f3813-907f-4c02-883f-15f58fbf4ab6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df88f2cb-27fe-4cfb-8e86-78e4243f635c","type":"EvidenceLine","dc:description":"Founder variant default scoring","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df88f2cb-27fe-4cfb-8e86-78e4243f635c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Founder variant ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/df88f2cb-27fe-4cfb-8e86-78e4243f635c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/578f3813-907f-4c02-883f-15f58fbf4ab6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","rdfs:label":"Family 3 II-3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001761","obo:HP_0010871","obo:HP_0000763","obo:HP_0002460"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/df88f2cb-27fe-4cfb-8e86-78e4243f635c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/fc021272-2e9c-483e-8a00-e0b7d241c5d3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be1cfd26-04bd-4ac1-8e1c-a8733cc579d1","type":"EvidenceLine","dc:description":"Founder variant default scoring\nPMID: 33751098","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be1cfd26-04bd-4ac1-8e1c-a8733cc579d1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Founder variant default scoring\nPMID: 33751098","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/be1cfd26-04bd-4ac1-8e1c-a8733cc579d1_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8930a49c-b3fa-490c-8066-0ccc4b834323","type":"EvidenceLine","dc:description":"Founder Variant ?","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8930a49c-b3fa-490c-8066-0ccc4b834323_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Recurrent variant see subject 1 scoring","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8930a49c-b3fa-490c-8066-0ccc4b834323_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fc021272-2e9c-483e-8a00-e0b7d241c5d3"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/4b020a8a-5c12-4e26-8fbb-b9bdde9f783e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd7b9901-cb23-4aee-8432-c4838efe6ccf","type":"EvidenceLine","dc:description":"Founder default","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd7b9901-cb23-4aee-8432-c4838efe6ccf_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Founder variant ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/cd7b9901-cb23-4aee-8432-c4838efe6ccf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3f0607f4-1e98-4ecf-a9ff-566513582148","type":"EvidenceLine","dc:description":"0.1 (default) + 0.4 (Western blot in constructed plasmid expressing W74C showed 70% decreased in COX20 expression HEK293T cells) + 0.4 ( WB in patient FCL shows reduced COX20 expression, COX20 mRNA by qPCR reduced as well)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f0607f4-1e98-4ecf-a9ff-566513582148_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 (default) + (0.4 Western blot in constructed plasmid expressing W74C showed 70% decreased in COX20 expression HEK293T cells)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3f0607f4-1e98-4ecf-a9ff-566513582148_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/eb98a859-82d3-4d22-b863-624852bbf88d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4b020a8a-5c12-4e26-8fbb-b9bdde9f783e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","rdfs:label":"Family 5 II-2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":14,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},{"id":"https://genegraph.clinicalgenome.org/r/eb98a859-82d3-4d22-b863-624852bbf88d"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000763","obo:HP_0001761","obo:HP_0010871"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/3f0607f4-1e98-4ecf-a9ff-566513582148_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/cd7b9901-cb23-4aee-8432-c4838efe6ccf_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1ff2a477-dc5e-4030-9768-5d8ca16a5f56_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7d5da76c-3592-4092-a97c-38af78af7add","type":"EvidenceLine","dc:description":"0.1 (default) + 0.4 (complex IV deficiency ~25% of control isolated) + 0.4 (patient cell expression showing increased in altered transcript (delta Exon2) expression relative to 6 WT controls) = 0.9 round to 1","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7d5da76c-3592-4092-a97c-38af78af7add_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Complex IV deficiency (26.5U/gNCP, normal: 112â€“351)\nThe full-length transcript seems to be present at\nlower levels in the mutation carrier compared to controls, while the\nnon-coding transcript seems to be more abundant, indicating a shift in\nsplicing.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7d5da76c-3592-4092-a97c-38af78af7add_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1ff2a477-dc5e-4030-9768-5d8ca16a5f56"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5a4ee588-a2b2-4943-acd5-e51644dcda23_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/56c6b2cf-9582-427b-9688-652d2bf87871","type":"EvidenceLine","dc:description":"This p.T52P variant is absent from gnomAD v.3.1.2\n\n0.1 (missense default) + 0 (not de novo) + unable to score functional evidence for variant in light of limited genomic studies-  retrospectively, genetic heterogeneity of complex IV deficiency was not accounted for","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/56c6b2cf-9582-427b-9688-652d2bf87871_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Extensive biochemical evidence- given genetic heterogeneity was unable to be accounted for, this will be scored at Gene level in experimental section","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/56c6b2cf-9582-427b-9688-652d2bf87871_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23125284","allele":{"id":"https://genegraph.clinicalgenome.org/r/66391759-c953-4e7f-8ab7-8520d5cf9d76"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/5a4ee588-a2b2-4943-acd5-e51644dcda23","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23125284","rdfs:label":"Case 1 Szklarczyk","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/66391759-c953-4e7f-8ab7-8520d5cf9d76"},"detectionMethod":"Sequencing of the mitochondrial DNA (mtDNA) of the index patient as well as nuclear genes known and postulated to be involved in complex IV deficiency did not reveal any mutations\nNuclear genes: (including COX10, COX15, SCO1, SCO2 and SURF1). They also sequenced additional human complex IV assembly candidates (AURKAIP1, CHCHD7, C7orf44, C1orf31 (COA6), PET117 (19) and\nCCDC56.\n\nNot tested: COX6B1, COA8\n\nFAM36A (COX20) Primers were designed from the Genbank accession number of the FAM36A gene (NM_198076). The primer sequences are available onrequest. The size of the PCR products were checked on a1.5% agarose gel before being directly sequenced using the\nBigDye terminator cycle on an ABI PRISM 3130xl Genetic\nAnalyzer (Applied Biosystems)","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"\"low weight\"","phenotypes":["obo:HP_0004322","obo:HP_0001251","obo:HP_0001252","obo:HP_0000750"],"secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/56c6b2cf-9582-427b-9688-652d2bf87871_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/8ccfd09d-49ec-485d-b863-831105a0e462_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/907004bc-6e7f-4e8c-a526-346fa40cfe26","type":"EvidenceLine","dc:description":"Founder variant baseline score is 0.5 per variant","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/907004bc-6e7f-4e8c-a526-346fa40cfe26_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Founder variant","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/907004bc-6e7f-4e8c-a526-346fa40cfe26_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/8ccfd09d-49ec-485d-b863-831105a0e462","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","rdfs:label":"Family 1 II-3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":17,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"Patient is currently 38","phenotypes":["obo:HP_0000763","obo:HP_0003693","obo:HP_0001324","obo:HP_0010871"],"secondTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/907004bc-6e7f-4e8c-a526-346fa40cfe26_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/040b52c2-b607-4e1f-b850-34d0c40fc858_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d0a840b-6ebd-4260-8157-27f28c0eadec","type":"EvidenceLine","dc:description":"Did not score functional data because figures supporting claim are missing from document ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d0a840b-6ebd-4260-8157-27f28c0eadec_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"As the patient-derived RNA of c.157+7A>G variant was not available, we developed a minigene assay to examine the effect of this variant on COX20 splicing (Supplementary Fig. 2A). Gel electrophoresis of mutant PCR products showed a shorter band with exon 2 skipped splicing pattern confirmed by sequencing (Supplementary Fig. 2B). The c.157+7A>G variant therefore caused the skipping of exon 2 resulting in a premature stop codon p.Ser15Valfs*11.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8d0a840b-6ebd-4260-8157-27f28c0eadec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/0c8f6e93-6033-4ca2-84f2-385d644847a0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000001.11:g.244842065A>G (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA424373843"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c655b469-e9e5-4984-8fc5-fc3f10c66110","type":"EvidenceLine","dc:description":"Founder variant default 0.5","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c655b469-e9e5-4984-8fc5-fc3f10c66110_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Founder variant default 0.5","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c655b469-e9e5-4984-8fc5-fc3f10c66110_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/040b52c2-b607-4e1f-b850-34d0c40fc858","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","rdfs:label":"Family 7 II-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":7,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/0c8f6e93-6033-4ca2-84f2-385d644847a0"},{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0010871","obo:HP_0001761","obo:HP_0000763"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c655b469-e9e5-4984-8fc5-fc3f10c66110_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/8d0a840b-6ebd-4260-8157-27f28c0eadec_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/ae9b52bb-20fe-4a97-8df5-482b6ce66e77_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6e0f04e-039f-4f05-a74b-09ee611347bc","type":"EvidenceLine","dc:description":"Founder variant default ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6e0f04e-039f-4f05-a74b-09ee611347bc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Founder variant","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d6e0f04e-039f-4f05-a74b-09ee611347bc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bf33b13e-e744-42e4-8392-7671d26467b3","type":"EvidenceLine","dc:description":"Occurs in exon 4, truncates last 33 aa's so could escape NMD, thus did not score as null and no functional evidence provided for this variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf33b13e-e744-42e4-8392-7671d26467b3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","allele":{"id":"https://genegraph.clinicalgenome.org/r/e545bbe1-626b-4cd4-bef0-a679eded5da6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198076.6(COX20):c.259C>T (p.Gln87Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345485234"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ae9b52bb-20fe-4a97-8df5-482b6ce66e77","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33751098","rdfs:label":"Family 8 II-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},{"id":"https://genegraph.clinicalgenome.org/r/e545bbe1-626b-4cd4-bef0-a679eded5da6"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002460","obo:HP_0001761","obo:HP_0000763","obo:HP_0010871","obo:HP_0001260"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/bf33b13e-e744-42e4-8392-7671d26467b3_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d6e0f04e-039f-4f05-a74b-09ee611347bc_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/2665b1bc-aadf-40e3-aae5-5bfebbddf7ff_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01936345-ab6f-4e2f-8b41-f3e2ec3a88d9","type":"EvidenceLine","dc:description":"The c.157+3G>C is seen in 96 alleles (0.0005617) 0 homozygotes gnomADv.3.1.2\n\n0.1 (default) + 0 for de novo + 0.4 (western showing absence of COX20 protein) + 0.4 (no full length cDNA, only transcript lacking exon 2) = 0.9 round to 1.0 given alternative transcript, was not scored as null","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01936345-ab6f-4e2f-8b41-f3e2ec3a88d9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 (default) + 0 for de novo + 0.4 (western showing absence of COX20 protein) + 0.4 (no full length cDNA, only transcript lacking exon 2) = 0.9 round to 1.0 given alternative transcript, was not scored as null","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/01936345-ab6f-4e2f-8b41-f3e2ec3a88d9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656193","allele":{"id":"https://genegraph.clinicalgenome.org/r/8649f44d-0204-4207-bf33-aeee2bc89d70"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f43d408e-8c70-434d-b5db-077afae806ec","type":"EvidenceLine","dc:description":"The c.41A>G is seen in 7 alleles (0.00004701) 0 homozygotes gnomADv.3.1.2\n\n0.1 (default) + 0 for de novo + 0.4 (western showing absence of COX20 protein) + 0.4 (no full length cDNA, only transcript lacking exon 2) = 0.9 round to 1.0 given alternative transcript, was not scored as null","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f43d408e-8c70-434d-b5db-077afae806ec_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 (default) + 0 for de novo + 0.4 (western showing absence of COX20 protein) + 0.4 (no full length cDNA, only transcript lacking exon 2) = 0.9 round to 1.0 given alternative transcript, was not scored as null","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/f43d408e-8c70-434d-b5db-077afae806ec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656193","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2665b1bc-aadf-40e3-aae5-5bfebbddf7ff","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656193","rdfs:label":"Subject 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/8649f44d-0204-4207-bf33-aeee2bc89d70"},{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"}],"detectionMethod":"No comment on ethnicity but nonconsanguineous","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000763","obo:HP_0001332","obo:HP_0001252","obo:HP_0001251","obo:HP_0001284","obo:HP_0001260"],"previousTesting":true,"previousTestingDescription":"ataxia genetic panel was negative and without abnormalities in SCA 1,2,3,5,6,7,10,14, DRPLA, SETX, POLG1, or FRDA1. She had an APTX variant of unknown significance, also present in her unaffected father.","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/01936345-ab6f-4e2f-8b41-f3e2ec3a88d9_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/f43d408e-8c70-434d-b5db-077afae806ec_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/00baf0f9-9499-4d3c-a435-ad5573b51811_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/461d67a0-9def-4e5c-85b3-e062072d9e3c","type":"EvidenceLine","dc:description":"Founder variant default scoring\nPMID: 33751098","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/461d67a0-9def-4e5c-85b3-e062072d9e3c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Founder variant default scoring\nPMID: 33751098","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/461d67a0-9def-4e5c-85b3-e062072d9e3c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656193","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1b5a9d2c-fa48-45ab-ae64-2a21e98c5c99","type":"EvidenceLine","dc:description":"Founder variant?","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b5a9d2c-fa48-45ab-ae64-2a21e98c5c99_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Founder variant?","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1b5a9d2c-fa48-45ab-ae64-2a21e98c5c99_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656193","allele":{"id":"https://genegraph.clinicalgenome.org/r/8649f44d-0204-4207-bf33-aeee2bc89d70"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/00baf0f9-9499-4d3c-a435-ad5573b51811","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30656193","rdfs:label":"Subject 4","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":18,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/c5a4483e-f024-4f10-acce-e0a56c900fac"},{"id":"https://genegraph.clinicalgenome.org/r/8649f44d-0204-4207-bf33-aeee2bc89d70"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000020","obo:HP_0100543","obo:HP_0001260","obo:HP_0001252","obo:HP_0001310","obo:HP_0001284","obo:HP_0002607","obo:HP_0001251","obo:HP_0000670","obo:HP_0000763"],"previousTesting":false,"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/1b5a9d2c-fa48-45ab-ae64-2a21e98c5c99_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/461d67a0-9def-4e5c-85b3-e062072d9e3c_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/2391b81d-cfd2-4862-b71b-0418794539c3_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2391b81d-cfd2-4862-b71b-0418794539c3_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32c3a88b-a127-474b-82ea-c1642baeb450","type":"EvidenceLine","dc:description":"Down weighted because specific complex IV activity was not measured ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a840b0aa-b7ed-40d1-ac8a-d1a012820a4b","type":"Finding","dc:description":"Co-immune precipitation experiments \nCox20 and Cox18 interact in a Cox2 dependent manner via co-immuneprecipitation (Figure 2)\n\ndelta Cox20 strain showed no respiratory growth in nonfermentable ethanol plus glycerol medium \nshowed growth in glucose\n\nWestern blotting were separated on 12% or 16% SDS-PAGE gels  and In vivo pulse-labeling of mitochondrial translation products show the delta Cox20 strain does not have mature Cox2 present and limited preCox2\n\nAll of the strains deficient in i-AAA protease activity were also analyzed in conjunction with delta Cox20 strains. The cox20Î” mutant accumulated substantially less pre-Cox2 than either the imp1Î” mutant or any of the cox20Î” strains deficient in i-AAA protease\n\nThese data suggest that Cox20 directly stabilizes pre-Cox2 against degradation by the i-AAA protease. \n\nResults strongly suggest that a third critical chaperone function of Cox20 is to protect as-yet-unassembled Cox2 from degradation by the i-AAA protease complex during the assembly process downstream of export. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22095077","rdfs:label":"Cox20 Chaperoning Activity of Cox2","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1690425a-98d1-47e1-9bcf-7e1bc6c30312","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9d5588b-b203-4d55-baab-7c68237fc6e3","type":"Finding","dc:description":"-The transduction of the patient cells with the wild-type protein resulted in increased levels of holocomplex IV\n-increased amounts of individual subunits of the complex (Fig. 4B) as well as measured\ncomplex IV enzyme activity (Fig. 4C and Table 2).\n\nThis was measured by spectrophotometry- complex IV activities; Complementation of patientâ€™s fibroblasts restores the complex IV activity from the patientâ€™s 36% to 71% of activity observed\nin a control cell line (P , 0.005, two-sided t-test\nControl+ mito import V5 = 744 mU/U CS\nControl+ FAM36A V5 = 765 mU/U CS\nPatient + mito import V5 = 267 mU/U CS\nPatient +FAM36AV5 = 530 mU/U CS\n\n-FAM36 transduction in the patient cell line has little or no effect on the activity of the\nother oxidative phosphorylation enzymes (Fig. 4D).\n\n-In the control cell line, transduction with FAM36A does not affect complex IV activity, showing that the complementation effect is specific to cells with deficient FAM36A (Fig. 4C).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23125284","rdfs:label":"Transduction with FAM36A-V5-containing lentivirus ","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2391b81d-cfd2-4862-b71b-0418794539c3_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aacfec7b-eca4-43ce-a544-9b13fc00a311","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a80e557-78e9-4a90-8f7f-2c12b1da4ef4","type":"FunctionalAlteration","dc:description":"Patient had muscle and skin biopsies that showed isolated complex IV deficiency by spectrophotometry which corrected for CS \nMsk: 99 (520â€“2080)\nFCL: 246 (470â€“860) mu/U CS\n\nComplex I, II+III fell within control range in muscle (II not measured)\nComplex I, II, II+III, fell within control range in FCL\nCS fell within control range in both FCL and msk\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23125284","rdfs:label":"Respiratory Chain Activity by Spectrophotometry in Msk+ FCL"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f745af84-2aba-4aa0-865e-936292eb2813","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98921725-7a3e-4326-af40-9894b0acd9f6","type":"FunctionalAlteration","dc:description":"Conducting siRNA-specific knockdown of endogenous COX20 expression in cultured HEK293T cells. \n\nConducting siRNA-specific knockdown of endogenous COX20 expression in cultured HEK293T cells.  which also showed reduced respiratory capacity to âˆ¼50% of the parental line (Fig. 2C), an effect that was a direct consequence of a severe, isolated CIV deficiency (Fig. 2D). \n\nCompared with the mock control, transient transfection of two different COX20-specific siRNA duplexes (Fig. 1A) led to an âˆ¼80% reduction in COX20 mRNA levels at Days 1, 2 and 3 (Fig. 1B and C). \nImmunoblot analysis confirmed the efficacy of knockdown at the protein level. Even though our affinity-purified anti-COX20 antibody cross-reacts strongly and non-specifically with larger proteins, it clearly detects a protein that migrates at the predicted molecular weight of COX20 (15 kDa) whose steady-state levels are markedly attenuated in COX20-silenced cells (Fig. 1D). \n\nThe net effect of COX20 silencing on mitochondrial metabolism was a decrease in endogenous cell respiratory capacity (Fig. 1E). The abundance of COX2 and COX3 subunits was significantly decreased in COX20-silenced cells, whereas the levels of COX1 or of subunits of other oxidative phosphorylation complexes were not affected (Fig. 1F). Consistent with these observations, Blue Native-polyacrylamide gel electrophoresis (BN-PAGE) analyses showed that COX20 silencing produced an isolated CIV deficiency (Fig. 1G) \n\n\nand led to the accumulation of assembly intermediates containing COX1 alone (S1) or at least COX1 and COX4 (S2 and S3) (Fig. 1H). These subassemblies correspond to the intermediates observed in cell lines derived from patients with mutations in the COX2 metallochaperone SCO1 or in the CIV assembly factor SURF1 (Fig. 1I). The CIV assembly defect in COX20-silenced cells is not due to a gross defect in COX2 synthesis as assessed by in vivo pulse-labeling of mitochondrial translation products. Rather, chase-labeling experiments showed that when COX20 levels are limiting, newly synthesized COX2 is unstable and most of it is rapidly degraded within 2 h of the chase (Fig. 1J). ATP6 was also found to be labile in this chase assay, although we did not observe any effect on the steady-state levels of the F1Fo ATPase (Fig. 1G). These results are consistent with the recently reported phenotype in fibroblasts derived from a COX20 patient (23), and suggest that COX2 is less stable upon depletion of COX20 because of a defect in its membrane insertion, maturation of its CuA site and/or a block in its incorporation into the S2 assembly intermediate.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24403053","rdfs:label":"COX20 knockdown and knockout studies  "}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2391b81d-cfd2-4862-b71b-0418794539c3_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c1115aff-cab4-485d-b9ed-f291b8f3ce8e","type":"EvidenceLine","dc:description":"Upgraded to 1 because interacts with at least 5 electron transport subunits or assembly factors (MT-CO1, MT-CO2, COX4I1 from this paper, SCO1 and SCO2 from a separate paper- see below) \n\nCOX5A not included, single case reported \n\nOf note, PMID: 24403053 adds SCO1 and SCO2 as having physical interactions as well by co-immune precipitation. Which makes 5 gene interactions, still score at 1 (2-5 gene interactions is 1 point)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c7d3f38-2ac8-4f13-b39b-14629fc659e0","type":"Finding","dc:description":"MT-CO1, MT-CO2, COX4 (COX4I1) all have multiple case reports of mitochondrial disease d/t complex IV deficiency\n\nCOX5A has only single case report so will be excluded (does not change scoring)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23125284","rdfs:label":"BN PAGE holocomplex IV assembly","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4}],"evidenceStrength":"Definitive","sequence":4735,"specifiedBy":"GeneValidityCriteria8","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/rv35VWN6zsg","type":"GeneValidityProposition","disease":"obo:MONDO_0044970","gene":"hgnc:26970","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2391b81d-cfd2-4862-b71b-0418794539c3-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}